Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants

David N. Springer, Michael Bauer, Iris Medits, Jeremy V. Camp, Stephan W. Aberle, Clemens Burtscher, Eva Höltl, Lukas Weseslindtner, Karin Stiasny, Judith H. Aberle
doi: https://doi.org/10.1101/2023.04.20.23288813

Article Information

doi 
https://doi.org/10.1101/2023.04.20.23288813
History 
  • April 25, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. David N. Springer1,
  2. Michael Bauer1,
  3. Iris Medits1,
  4. Jeremy V. Camp1,
  5. Stephan W. Aberle1,
  6. Clemens Burtscher2,
  7. Eva Höltl2,3,
  8. Lukas Weseslindtner1,
  9. Karin Stiasny1,4,* and
  10. Judith H. Aberle1,4,*
  1. 1Center for Virology, Medical University of Vienna, Austria
  2. 2Health Center Erste Bank, Erste Bank, Vienna, Austria
  3. 3Center for Public Health, Medical University of Vienna, Austria
  1. ↵*Correspondence to karin.stiasny{at}meduniwien.ac.at and judith.aberle{at}meduniwien.ac.at.

  1. ↵4 These authors contributed equally.

Back to top
Posted April 25, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
David N. Springer, Michael Bauer, Iris Medits, Jeremy V. Camp, Stephan W. Aberle, Clemens Burtscher, Eva Höltl, Lukas Weseslindtner, Karin Stiasny, Judith H. Aberle
medRxiv 2023.04.20.23288813; doi: https://doi.org/10.1101/2023.04.20.23288813
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area